Loading...
XSHG
688677
, Last price  
Name

Qingdao NovelBeam Technology Co Ltd

Chart & performance

D1W1MN
XSHG:688677 chart
P/E
—
P/S
—
EPS
1.96
Vol. 1Y
—
Shs. 5Y
5.51%
Rev. 5Y
16.97%
Div Yld LY
—
Div Yld TTM
—
Revenues
603m
+36.08%
51,931,26267,968,89773,735,308139,489,581181,035,017200,680,727252,866,319275,197,324309,674,983476,821,311470,597,323442,830,242602,611,400
Net income
171m
+26.15%
-931,3596,620,73215,541,54932,769,14251,092,76754,554,46771,930,85296,351,775117,730,500182,569,602145,712,651135,348,544170,744,189
CFO
160m
+42.25%
21,786,79513,745,35316,035,65636,617,71666,059,93748,339,72283,539,980114,777,995104,005,918104,375,771158,117,742112,322,742159,781,415
Dividend
Jun 10, 20260.6 /sh
Earnings
Oct 24, 2026

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Qingdao NovelBeam Technology Co., Ltd. is a global provider of optical components and advanced solutions for the medical, life science, laser, and micro-display projection industries. Its comprehensive offerings include specialized medical endoscopy devices such as endoscopes, camera couplers, camera lenses, and light source modules. Additionally, the company supplies a range of optical products covering medical optics, industrial and laser applications, and biometric systems. Established in 2003, the firm maintains its headquarters in Qingdao, China.
IPO date
Feb 26, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT